Archive for May, 2008

FAME study can continue without change

EyepSivida Limited has announced that the FAME™ (Fluocinolone Acetonide in Diabetic Macular Edema) Study can continue under the current protocol. The trial is studying the use of Medidur FA in diabetic macular edema (DME). The FAME™ study is being conducted on 956 patients in the U.S., Canada, Europe and India and it consists of two, duplicate, double-masked, randomized and multi-center trials.

Photo by R’eyes

Research shows lower CSF pressure in glaucoma patients

Researchers have found that cerebrospinal fluid (CSF) pressure was a third lower in patients with primary open-angle glaucoma than in those who did not have the condition. The group of researchers led by John Berdahl also found in a retrospective case-control study that intraocular pressure (IOP) was similar between patients with glaucoma and those with other vision defects. The research published in the May issue of Ophthalmology suggests that the pressure difference between the intraocular space and the CSF space, the so-called translaminar pressure difference, may play a role in the pathogenesis of glaucoma.

Soft contact lens do not accelerate myopia progression

ContactA new study shows that soft contact lens wear does not accelerate the development of nearsightedness in children. Findings from the largest randomized three-year study, which tracked the myopic progression of 484 children ages 8-11 randomly assigned to wear glasses or contact lenses, indicated that there was no clinically meaningful difference between the two forms of vision correction for the treatment of nearsightedness, a vision problem experienced by approximately one-third of the population. The new research further dispels a long held myth that soft contact lenses increase myopia progression more than other vision correction options.

Carl Zeiss Meditec launches two new OCT applications

Zeiss LogoCarl Zeiss Meditec has announced that two new optical coherence tomography (OCT) applications, Cirrus™ HD-OCT and Stratus™ OCT, will be made available at the American Society of Cataract and Refractive Surgeons meeting in Chicago for the first time. These are among the most advanced imaging technologies available for assessment and management of glaucoma and diseases of the retina.